Latest Market Positioning News

Sprintex Limited has boosted its Türkiye presence by extending its exclusive distribution deal, securing a new A$377,000 order, and launching larger Jet Blowers aimed at industrial and municipal markets.

TALi Digital has successfully raised $800,000 through a private placement to fuel the commercialisation of its digital health products aimed at enhancing childhood cognitive attention.

Mayne Pharma shareholders have overwhelmingly approved a scheme for Cosette Pharmaceuticals to acquire the company, setting the stage for a pivotal court hearing later this year.

Aquirian Limited unveils a strategic growth plan centered on its Wubin Energetics hub and proprietary Collar Keeper® technology, aiming to boost revenue and operational efficiency amid rising mining demand.

Critical Metals Corp has landed a conditional US$120 million funding letter from the US Export-Import Bank to advance its Tanbreez rare earth project in Greenland, a move that could reshape Western critical minerals supply chains.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Top End Energy updates its Northern Territory exploration strategy amid record gas flow tests in the Beetaloo Basin, signaling a shift from appraisal to development.

Hazer Group Limited has opened a $2 million underwritten Share Purchase Plan, offering eligible shareholders in Australia and New Zealand the chance to buy shares at the same price as a recent institutional placement. The funds will support the commercialisation of its methane reactor technology and synthetic graphite development.

Trading in Alphinity Global Equity Fund's Active ETF (XALG) has been temporarily halted, with personal trading also paused pending further announcements.

IVE Group has raised its FY25 underlying NPAT guidance to approximately $52 million, driven by margin expansion despite a slight revenue dip. The company also outlined ambitious growth plans targeting $1.25 billion in revenue by 2030, focusing on diversified, sustainable marketing solutions.

Harvest Technology Group reports it is one year ahead of its 3-Year Pathway to Profit plan, forecasting a significant reduction in EBITDA loss for FY25 and unveiling plans for its AI-powered NEON platform launch in 1H26.

CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.